Re-Mission, the video simulation known to change young patients' attitudes toward cancer, is in its second iteration. And one big drug maker has added its backing.
Proteus Digital Health's ingestible sensor shows utility as an adherence tool for those on psych meds, a study suggests.
The drug maker, through its venture fund, took a controlling interest in the digital physician marketing firm.
The duo whose nonprofit served as neutral ground for getting FDA and industry talking about digital marketing is starting a for-profit research and advisory firm.
R.J. Lewis, President and CEO of e-Healthcare Solutions, offers his unique take on digital pharma trends in a conversation with MM&M Editor in Chief, James Chase. [SPONSORED CONTENT]
*Group discounts available on request
Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.